Anthropic, the AI company best known for building Claude, is making a deliberate push into the pharmaceutical world. The company launched its AI for Science program on May 5, 2025, offering free API credits to researchers working on drug discovery, genetics, and biology projects.
What the program actually does
The AI for Science program is designed to give qualified researchers access to Anthropic’s models at no cost. The research needs to focus on areas with significant potential impact, specifically biology, life sciences, genetic data analysis, and drug discovery for major global diseases.
The initiative is closely tied to CEO Dario Amodei’s publicly stated vision of using AI for broad societal benefit. The scope isn’t limited to one narrow application. Researchers can use the credits to work on understanding complex biological systems, analyzing genetic information, or accelerating the traditionally glacial process of identifying drug candidates.
From chatbots to clinical research
